{"id":275181,"date":"2022-09-09T08:44:40","date_gmt":"2022-09-09T13:44:40","guid":{"rendered":"https:\/\/www.liveaction.org\/news\/?p=275181"},"modified":"2022-09-08T14:00:31","modified_gmt":"2022-09-08T19:00:31","slug":"abortion-industry-test-abortion-pill-contraceptive","status":"publish","type":"post","link":"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/","title":{"rendered":"Abortion industry plan to test abortion pill as a contraceptive blurs line on abortion"},"content":{"rendered":"
<\/div>

Rebecca Gomperts \u2014\u00a0founder of Women on Waves, Women on Web, and Aid Access \u2014\u00a0is raising funds to conduct a clinical trial in the Republic of Moldova<\/a> with the objective of “declar[ing] the abortion pill a contraceptive.”<\/p>\n

The goal of this move, she admits, is to blur the line between “contraception and what an abortion is.”<\/p>\n

Gomperts’ plan,\u00a0detailed<\/a> on her Women on Waves website, is described as a “new strategy to advance our reproductive freedom.”\u00a0It claims that categorizing the abortion pill as a contraceptive would “allow us to move flexibly between the medicine\u2019s different indications as weekly contraceptive, as an on-demand method used before or after sexual intercourse or as an early medical abortion method, depending on our life circumstances.”<\/p>\n

Gomperts’\u00a0crowdfunding page<\/a> states that she has already raised $500K and is now\u00a0seeking<\/a>\u00a0an additional $500K to begin “[a]n international experienced medical, scientific and ethics team… to conduct these larger clinical trials in keeping with the requirements of the FDA and European Medicine Agency (EMA), which has advised on this project.”<\/p>\n

In an interview<\/a> with Democracy Now, Gomperts’ motives were made clearer when she claimed that by making the abortion pill available as a once-a-week contraceptive or morning after pill, the industry would actually be “blurring the line between anticonception or contraception and what an abortion is.” She later added that by making mifepristone available as a contraceptive, “it will be much less regulated and possibly over-the-counter in the future.”<\/p>\n

In June, Gomperts told Business Insider<\/a> that her goal is to have “a 50 milligram dose of mifepristone for use as a weekly, on-demand contraceptive on pharmacy shelves within 10 years.”\u00a0According to the media outlet, “Women on Web<\/a>\u00a0has the ethical approval of the Ministry of Health of Moldova to run a study because 50 milligrams of mifepristone is already on the market there for treatment of myomas, non-cancerous tumors that can form in or around the uterus,” Business Insider reported.<\/p>\n

READ:\u00a0New data shows abortion pill has ended the lives of 5 million preborn babies in US<\/a><\/em><\/strong><\/p>\n

Gomperts’ GoFundMe page<\/a> claimed that previous studies have been conducted on mifepristone as a contraceptive. While failing to point to any published results, Gomperts cited the need for more “extensive studies” but also claimed that “because mifepristone is not patented anymore, pharmaceutical companies are not interested in investing in these trials.”<\/p>\n

\"Image:

medication abortion is not contraceptives’ (Image: Twitter)<\/p><\/div>\n

Gomperts is allegedly working with Kristina Gemzell Danielsson<\/a>, a professor of obstetrics and gynecology at the Karolinska Institute<\/a> to assist with the study.\u00a0According to a report published in\u00a0The Verge<\/a>, the two plan to recruit nearly 1,000 women in the Netherlands and Moldova for the\u00a0year-long clinical trial. ‘The study was designed in keeping with FDA and European Medical Agency protocols and has already recruited seven hospitals as participants and secured all the necessary clinical and ethical approvals to begin the study in Moldova,” The Verge wrote.<\/p>\n

“To complete the study of 949 women using weekly mifepristone for a year, to provide the data we need in order to register it as a weekly contraceptive with the EMA, we need 2.2 million euro,” Gomperts also wrote<\/a> on her page, adding,\u00a0“Even if states ban the abortion pill, this new on demand contraceptive method can always be accessible through local or international (telemedical) services.”<\/p>\n

In the U.S., the abortion pill (Mifeprex or mifepristone) was\u00a0approved<\/a>\u00a0in 2000 in a regimen with the drug misoprostol (which was not initially\u00a0approved<\/a>\u00a0for use in pregnancy). Shortly after its approval, mifepristone was placed under a safety system called REMS, an acronym which stands for\u00a0Risk Evaluation and Mitigation Strategy, which the\u00a0FDA<\/a>\u00a0can put in place \u201cfor certain medications with\u00a0serious safety concerns<\/a>.” Live Action News has\u00a0previously<\/a>\u00a0detailed the FDA\u2019s concern over the safety of the abortion pill, which led to the April 2011 decision<\/a> by the FDA\u00a0that the\u00a0REMS<\/a>\u00a0safety requirement was\u00a0necessary<\/em>\u00a0for mifepristone. Those REMS requirements were recently altered<\/a> by the FDA under the Biden administration.<\/p>\n

\u201cLike\u201d Live Action News on Facebook<\/a>\u00a0for more pro-life news and commentary!<\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Rebecca Gomperts \u2014\u00a0founder of Women on Waves, Women on Web, and Aid Access \u2014\u00a0is raising funds to conduct a clinical trial in the Republic of Moldova with the objective of “declar[ing] the abortion pill a contraceptive.” The goal of this move, she admits, is to blur the line between “contraception and what an abortion is.” […]<\/p>\n","protected":false},"author":303,"featured_media":275654,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false},"categories":[9953],"tags":[],"yoast_head":"\nAbortion industry plan to test abortion pill as a contraceptive blurs line on abortion<\/title>\n<meta name=\"description\" content=\"Rebecca Gomperts, Women on Waves founder,\u00a0is raising funds to conduct a clinical trial with the goal of "declar[ing] the abortion pill a contraceptive."\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abortion industry plan to test abortion pill as a contraceptive blurs line on abortion\" \/>\n<meta property=\"og:description\" content=\"Rebecca Gomperts, Women on Waves founder,\u00a0is raising funds to conduct a clinical trial with the goal of "declar[ing] the abortion pill a contraceptive."\" \/>\n<meta property=\"og:url\" content=\"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/\" \/>\n<meta property=\"og:site_name\" content=\"Live Action News\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/liveaction\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-09T13:44:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-08T19:00:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/09\/Rebecca-Gomperts-Women-on-Waves-Aid-Access-and-Women-on-Web-wants-abortion-pill-as-contraceptive-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1195\" \/>\n\t<meta property=\"og:image:height\" content=\"649\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Carole Novielli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/twitter.com\/CaroleNovielli\" \/>\n<meta name=\"twitter:site\" content=\"@liveaction\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Carole Novielli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/\"},\"author\":{\"name\":\"Carole Novielli\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/81ff4ca810d98b0b5b376a640452d9e6\"},\"headline\":\"Abortion industry plan to test abortion pill as a contraceptive blurs line on abortion\",\"datePublished\":\"2022-09-09T13:44:40+00:00\",\"dateModified\":\"2022-09-08T19:00:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/\"},\"wordCount\":696,\"publisher\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\"},\"articleSection\":[\"Abortion Pill\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/\",\"url\":\"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/\",\"name\":\"Abortion industry plan to test abortion pill as a contraceptive blurs line on abortion\",\"isPartOf\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#website\"},\"datePublished\":\"2022-09-09T13:44:40+00:00\",\"dateModified\":\"2022-09-08T19:00:31+00:00\",\"description\":\"Rebecca Gomperts, Women on Waves founder,\u00a0is raising funds to conduct a clinical trial with the goal of \\\"declar[ing] the abortion pill a contraceptive.\\\"\",\"breadcrumb\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/archive.liveaction.org\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abortion industry plan to test abortion pill as a contraceptive blurs line on abortion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#website\",\"url\":\"https:\/\/archive.liveaction.org\/news\/\",\"name\":\"Live Action News\",\"description\":\"Covering Human Rights, Abortion, & Pro-Life Issues\",\"publisher\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/archive.liveaction.org\/news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\",\"name\":\"Live Action\",\"url\":\"https:\/\/archive.liveaction.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png\",\"contentUrl\":\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png\",\"width\":701,\"height\":710,\"caption\":\"Live Action\"},\"image\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/liveaction\",\"https:\/\/twitter.com\/liveaction\",\"https:\/\/www.instagram.com\/liveactionorg\/\",\"https:\/\/www.pinterest.com\/LiveActionFilms\/\",\"https:\/\/www.youtube.com\/user\/LiveActionFilms\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/81ff4ca810d98b0b5b376a640452d9e6\",\"name\":\"Carole Novielli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/df095be9fa34b48e50413a07102ab289?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/df095be9fa34b48e50413a07102ab289?s=96&d=mm&r=g\",\"caption\":\"Carole Novielli\"},\"description\":\"Carole Novielli has over thirty years of research experience on abortion, Planned Parenthood and eugenics. Her work has been published by many reputable media outlets. As a woman opposed to abortion, Carole is a committed Christian who refuses to be silenced by the main stream media and the nation's pro-abortion feminist minority.\",\"sameAs\":[\"https:\/\/twitter.com\/https:\/\/twitter.com\/CaroleNovielli\"],\"url\":\"https:\/\/archive.liveaction.org\/news\/author\/carole\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abortion industry plan to test abortion pill as a contraceptive blurs line on abortion","description":"Rebecca Gomperts, Women on Waves founder,\u00a0is raising funds to conduct a clinical trial with the goal of \"declar[ing] the abortion pill a contraceptive.\"","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/","og_locale":"en_US","og_type":"article","og_title":"Abortion industry plan to test abortion pill as a contraceptive blurs line on abortion","og_description":"Rebecca Gomperts, Women on Waves founder,\u00a0is raising funds to conduct a clinical trial with the goal of \"declar[ing] the abortion pill a contraceptive.\"","og_url":"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/","og_site_name":"Live Action News","article_publisher":"https:\/\/www.facebook.com\/liveaction","article_published_time":"2022-09-09T13:44:40+00:00","article_modified_time":"2022-09-08T19:00:31+00:00","og_image":[{"width":1195,"height":649,"url":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/09\/Rebecca-Gomperts-Women-on-Waves-Aid-Access-and-Women-on-Web-wants-abortion-pill-as-contraceptive-2.jpg","type":"image\/jpeg"}],"author":"Carole Novielli","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/twitter.com\/CaroleNovielli","twitter_site":"@liveaction","twitter_misc":{"Written by":"Carole Novielli","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/#article","isPartOf":{"@id":"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/"},"author":{"name":"Carole Novielli","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/81ff4ca810d98b0b5b376a640452d9e6"},"headline":"Abortion industry plan to test abortion pill as a contraceptive blurs line on abortion","datePublished":"2022-09-09T13:44:40+00:00","dateModified":"2022-09-08T19:00:31+00:00","mainEntityOfPage":{"@id":"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/"},"wordCount":696,"publisher":{"@id":"https:\/\/archive.liveaction.org\/news\/#organization"},"articleSection":["Abortion Pill"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/","url":"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/","name":"Abortion industry plan to test abortion pill as a contraceptive blurs line on abortion","isPartOf":{"@id":"https:\/\/archive.liveaction.org\/news\/#website"},"datePublished":"2022-09-09T13:44:40+00:00","dateModified":"2022-09-08T19:00:31+00:00","description":"Rebecca Gomperts, Women on Waves founder,\u00a0is raising funds to conduct a clinical trial with the goal of \"declar[ing] the abortion pill a contraceptive.\"","breadcrumb":{"@id":"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/archive.liveaction.org\/news\/abortion-industry-test-abortion-pill-contraceptive\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/archive.liveaction.org\/news\/"},{"@type":"ListItem","position":2,"name":"Abortion industry plan to test abortion pill as a contraceptive blurs line on abortion"}]},{"@type":"WebSite","@id":"https:\/\/archive.liveaction.org\/news\/#website","url":"https:\/\/archive.liveaction.org\/news\/","name":"Live Action News","description":"Covering Human Rights, Abortion, & Pro-Life Issues","publisher":{"@id":"https:\/\/archive.liveaction.org\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/archive.liveaction.org\/news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/archive.liveaction.org\/news\/#organization","name":"Live Action","url":"https:\/\/archive.liveaction.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png","contentUrl":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png","width":701,"height":710,"caption":"Live Action"},"image":{"@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/liveaction","https:\/\/twitter.com\/liveaction","https:\/\/www.instagram.com\/liveactionorg\/","https:\/\/www.pinterest.com\/LiveActionFilms\/","https:\/\/www.youtube.com\/user\/LiveActionFilms"]},{"@type":"Person","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/81ff4ca810d98b0b5b376a640452d9e6","name":"Carole Novielli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/df095be9fa34b48e50413a07102ab289?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/df095be9fa34b48e50413a07102ab289?s=96&d=mm&r=g","caption":"Carole Novielli"},"description":"Carole Novielli has over thirty years of research experience on abortion, Planned Parenthood and eugenics. Her work has been published by many reputable media outlets. As a woman opposed to abortion, Carole is a committed Christian who refuses to be silenced by the main stream media and the nation's pro-abortion feminist minority.","sameAs":["https:\/\/twitter.com\/https:\/\/twitter.com\/CaroleNovielli"],"url":"https:\/\/archive.liveaction.org\/news\/author\/carole\/"}]}},"_links":{"self":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/275181"}],"collection":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/users\/303"}],"replies":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/comments?post=275181"}],"version-history":[{"count":19,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/275181\/revisions"}],"predecessor-version":[{"id":275676,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/275181\/revisions\/275676"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/media\/275654"}],"wp:attachment":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/media?parent=275181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/categories?post=275181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/tags?post=275181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}